Grundlæggende statistik
| CIK | 1404943 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to MetaStat, Inc.
SEC Filings (Chronological Order)
Denne side giver en komplet, kronologisk liste over SEC-arkiveringer, eksklusive ejerskabsregistreringer, som vi leverer andre steder.
| July 16, 2018 |
United States Securities and Exchange Commission Washington, D.C. 20549 FORM 15 Certification and Notice of Termination of Registration under Section 12(g) of the Securities Exchange Act of 1934 or Suspension of Duty to File Reports Under Sections 13 and 15(d) of the Securities Exchange Act of 1934 Commission File Number 000- 52735 METASTAT, INC. (Exact name of registrant as specified in its chart |
|
| July 16, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): July 16, 2018 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 20-8753132 (Commission File Number) |
|
| July 16, 2018 |
Exhibit 99.1 MetaStat Voluntarily Withdraws Listing on the OTCQB and Files Form 15 to Suspend its Reporting Obligations BOSTON, July 16, 2018 (BUSINESS WIRE) - MetaStat, Inc. (OTCQB: MTST) (the “Company”), a precision medicine company developing novel anti-metastatic drugs for the treatment of patients with aggressive cancer, today announced the Company is voluntarily deregistering its common stoc |
|
| May 29, 2018 |
MTST / MetaStat, Inc. ANNUAL REPORT (Annual Report) U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (MARK ONE) [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended February 28, 2018 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission file number: 000-52735 METASTAT, INC. (Exa |
|
| May 25, 2018 |
MTST / MetaStat, Inc. POST EFFECTIVE AMENDMENT TO FORM S-1 As filed with the Securities and Exchange Commission on May 25, 2018 Registration No. |
|
| May 25, 2018 |
MTST / MetaStat, Inc. POST EFFECTIVE AMENDMENT NO. 2 As filed with the Securities and Exchange Commission on May 25, 2018 Registration No. |
|
| April 5, 2018 |
METASTAT, INC. Junior Non-Convertible Promissory Bridge Note Exhibit 4.2 THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES LAWS AND MAY NOT BE SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS REGISTERED UNDER THE SECURITIES ACT AND UNDER APPLICABLE STATE SECURITIES LAWS OR UNLESS METASTAT, INC. SHALL HAVE RECEIVED AN OPINION OF COUNSEL THAT THE REGISTRATION OF SUCH SECURITIES UNDE |
|
| April 5, 2018 |
METASTAT, INC. Senior Non-Convertible Promissory Bridge Note Exhibit 4.1 THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES LAWS AND MAY NOT BE SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS REGISTERED UNDER THE SECURITIES ACT AND UNDER APPLICABLE STATE SECURITIES LAWS OR UNLESS METASTAT, INC. SHALL HAVE RECEIVED AN OPINION OF COUNSEL THAT THE REGISTRATION OF SUCH SECURITIES UNDE |
|
| April 5, 2018 |
COMMON STOCK PURCHASE WARRANT METASTAT, INC. Exhibit 4.3 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
| April 5, 2018 |
Exhibit 10.2 EXCHANGE AGREEMENT This EXCHANGE AGREEMENT (this “Agreement”) is made effective as of March 30, 2018 (the “Execution Date”) by and among MetaStat, Inc., a Nevada corporation (the “Company”) and [] (the “Investor”). RECITALS WHEREAS, the Company and the Investor entered into a securities purchase agreement dated as of December 31, 2014, as amended on March 27, 2015 (the “Series B Purch |
|
| April 5, 2018 |
Exhibit 10.1 NOTE PURCHASE AGREEMENT This Note Purchase Agreement (this “Agreement”) is made as of March 30, 2018 by and between MetaStat, Inc. (the “Company”), a Nevada corporation, with offices at 27 Drydock Ave., 2nd Floor, Boston MA 02210 and the purchasers listed on Exhibit A attached hereto (the “Purchasers”). WHEREAS, the Company desires to sell to the Purchasers, and the Purchasers desire |
|
| April 5, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 30, 2018 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 (Commission File Number) 20-875313 |
|
| January 16, 2018 |
MTST / MetaStat, Inc. QUARTERLY REPORT (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 30, 2017 OR [ ] TRANSITION REPORT UNDER SECTION 13 OF 15(d) OF THE EXCHANGE ACT OF 1934 From the transition period from to . Commission File Number 000-52735 METASTAT, INC. (E |
|
| January 12, 2018 |
MTST / MetaStat, Inc. / Empery Asset Management, LP - METASTAT, INC. Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* MetaStat, Inc. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 59140A203 (CUSIP Number) December 31, 2017 (Date of event which requires filing of this statement) Check the appropriate box to designate the rule pursuant to which this Sch |
|
| November 2, 2017 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 31, 2017 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 20-8753132 (Commission File |
|
| November 2, 2017 |
METASTAT, INC. EMPLOYMENT AGREEMENT Blueprint Exhibit 10.1 METASTAT, INC. EMPLOYMENT AGREEMENT This Employment Agreement (this ?Agreement?) is made and entered into on October 31, 2017 (the ?Effective Date?) by and between MetaStat, Inc. (the ?Company?) and Douglas Hamilton (?Executive?). The Company and Executive are hereinafter collectively referred to as the ?Parties?, and individually referred to as a ?Party?. Recitals A. The Co |
|
| October 16, 2017 |
MTST / MetaStat, Inc. FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended August 31, 2017 OR [ ] TRANSITION REPORT UNDER SECTION 13 OF 15(d) OF THE EXCHANGE ACT OF 1934 From the transition period from to . Commission File Number 000-52735 METASTAT, INC. (Exa |
|
| October 5, 2017 |
As filed with the Securities and Exchange Commission on October 5, 2017 As filed with the Securities and Exchange Commission on October 5, 2017 Registration No. |
|
| August 22, 2017 |
MTST 8K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 18, 2017 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 20-8753132 (Commission Fi |
|
| August 7, 2017 |
SEC Connect UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 3, 2017 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 20-8753132 (Commission |
|
| July 17, 2017 |
MTST / MetaStat, Inc. FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended May 31, 2017 OR [ ] TRANSITION REPORT UNDER SECTION 13 OF 15(d) OF THE EXCHANGE ACT OF 1934 From the transition period from to . Commission File Number 000-52735 METASTAT, INC. (Exact |
|
| June 27, 2017 |
SEC Connect Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (this ?Agreement?) is dated as of [], 2017 by and among MetaStat, Inc., a Nevada corporation (the ?Company?), and the purchasers listed on Exhibit A attached hereto (each a ?Purchaser? and collectively, the ?Purchasers?), for the purchase and sale of shares of the Company?s common stock, par value $0.001 per |
|
| June 27, 2017 |
SEC Connect UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 23, 2017 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 20-8753132 (Commission |
|
| June 27, 2017 |
MetaStat Closes First Round of a $7 million Private Placement Blueprint Exhibit 99.1 MetaStat Closes First Round of a $7 million Private Placement Boston, MA, June 27, 2017 - MetaStat, Inc. (OTCQB: MTST), a personalized medicine company developing therapeutic and diagnostic treatment solutions for cancer patients, announced today it has consummated an initial closing of a private placement of up to $7 million of its common stock. The offering resulting in gr |
|
| June 19, 2017 |
Blueprint Exhibit 99.1 MetaStat Announces Completion of Second Milestone of its Pilot Research Project with Celgene Corporation Boston, MA., June 19, 2017 - MetaStat, Inc. (OTCQB: MTST), a personalized medicine company developing therapeutic and diagnostic treatment solutions for cancer patients, announced today it has completed the second milestone under its pilot research project with Celgene Co |
|
| June 19, 2017 |
Financial Statements and Exhibits, Other Events SEC Connect UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 16, 2017 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 20-8753132 (Commission |
|
| May 31, 2017 |
SEC Connect UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 24, 2017 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 20-8753132 (Commission F |
|
| May 30, 2017 |
U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (MARK ONE) [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended February 28, 2017 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission file number: 000-52735 METASTAT, INC. (Exa |
|
| May 8, 2017 |
SEC Connect UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 3, 2017 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 20-8753132 (Commission Fi |
|
| April 28, 2017 |
SEC Connect UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 25, 2017 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 20-8753132 (Commission |
|
| February 16, 2017 |
Unregistered Sales of Equity Securities, Other Events SEC Connect UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 15, 2017 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 20-8753132 (Commiss |
|
| January 23, 2017 |
COMMON STOCK PURCHASE WARRANT METASTAT, INC. Exhibit 4.2 Exhibit 4.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFEC |
|
| January 23, 2017 |
METASTAT, INC. Convertible Promissory Note Exhibit 4.1 Exhibit 4.1 THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES LAWS AND MAY NOT BE SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS REGISTERED UNDER THE SECURITIES ACT AND UNDER APPLICABLE STATE SECURITIES LAWS OR UNLESS METASTAT, INC. SHALL HAVE RECEIVED AN OPINION OF COUNSEL THAT THE REGISTRATION OF SUCH SEC |
|
| January 23, 2017 |
8-K 1 mtst8kjan232017.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 17, 2017 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-527 |
|
| January 23, 2017 |
Exhibit 10.1 Exhibit 10.1 EXCHANGE AGREEMENT This EXCHANGE AGREEMENT (this ?Agreement?) is made effective as of January 17, 2017 (the ?Execution Date?) by and among MetaStat, Inc., a Nevada corporation (the ?Company?) and Dolphin Offshore Partners, L.P. (the ?Investor?). RECITALS WHEREAS, the Company and the Investor entered into that certain Note Purchase Agreement dated July 30, 2015 (the ?Note |
|
| January 17, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 30, 2016 OR [ ] TRANSITION REPORT UNDER SECTION 13 OF 15(d) OF THE EXCHANGE ACT OF 1934 From the transition period from to . Commission File Number 000-52735 METASTAT, INC. (E |
|
| January 5, 2017 |
PROSPECTUS METASTAT, INC. 5,834,422 shares of Common Stock SEC Connect Filed Pursuant to Rule 424(b)(3) Registration No. 333-215101 PROSPECTUS METASTAT, INC. 5,834,422 shares of Common Stock This prospectus relates to the resale, from time to time, of up to 5,834,422 shares of our common stock, par value $.0001 per share (the ?Common Stock?), being offered by the selling stockholders identified in this prospectus. The shares of Common Stock offered under |
|
| January 4, 2017 |
SEC Connect January 4, 2017 Securities and Exchange Commission 450 Fifth Street, N. |
|
| January 3, 2017 |
MetaStat AMENDMENT NO. 1 TO FORM S-1 SEC Connect As filed with the Securities and Exchange Commission on January 3, 2017 Registration No. |
|
| December 14, 2016 |
As filed with the Securities and Exchange Commission on December 14, 2016 As filed with the Securities and Exchange Commission on December 14, 2016 Registration No. |
|
| November 3, 2016 |
Unregistered Sales of Equity Securities, Financial Statements and Exhibits SEC Connect UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 28, 2016 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 (Commission File Num |
|
| October 27, 2016 |
SEC Connect UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 21, 2016 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 20-8753132 (Commissi |
|
| October 25, 2016 |
MTST / MetaStat, Inc. / Empery Asset Management, LP - METASTAT, INC. Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* MetaStat, Inc. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 59140A203 (CUSIP Number) October 20, 2016 (Date of event which requires filing of this statement) Check the appropriate box to designate the rule pursuant to which this Sched |
|
| October 17, 2016 |
Blueprint Exhibit 4.2 METASTAT, INC. CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES A-2 CONVERTIBLE PREFERRED STOCK WHEREAS, the Articles of Incorporation of MetaStat, Inc., a Nevada corporation (the “Corporation”) provides for a class of its authorized stock known as preferred stock, comprised of 10,000,000 shares, issuable from time to time in one or more series; WHE |
|
| October 17, 2016 |
COMMON STOCK PURCHASE WARRANT METASTAT, INC. Blueprint Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTI |
|
| October 17, 2016 |
Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities 8-K 1 mtst8koct2016.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 11, 2016 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 |
|
| October 17, 2016 |
Blueprint Exhibit 10.1 SUBSCRIPTION AGREEMENT This SUBSCRIPTION AGREEMENT (this ?Agreement?) is made and entered into as of , 2016, by and among MetaStat, Inc., a Nevada corporation (the ?Company?), and each of the eligible investors who executes this Agreement and whose names are set forth on the signature pages hereto (individually, a ?Subscriber? and collectively, the ?Subscribers?). RECITALS W |
|
| October 17, 2016 |
Blueprint Exhibit 10.2 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this “Agreement”) is made and entered into as of [], 2016, by and among MetaStat, Inc., a Nevada corporation (the “Company”), and the subscribers signatory hereto (each, a “Subscriber” and collectively, the “Subscribers”). This Agreement is made pursuant to Subscription Agreement, dated on or about the date he |
|
| October 14, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended August 31, 2016 OR [ ] TRANSITION REPORT UNDER SECTION 13 OF 15(d) OF THE EXCHANGE ACT OF 1934 From the transition period from to . Commission File Number 000-52735 METASTAT, INC. (Exa |
|
| October 6, 2016 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits Blueprint UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): September 29, 2016 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 20-8753132 (Commissi |
|
| October 6, 2016 |
Blueprint Exhibit 10.2 CONFIDENTIAL TREATMENT REQUESTED. INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND MARKED WITH “****” OR OTHERWISE CLEARLY INDICATED. AN UNREDACTED VERSION OF THIS DOCUMENT HAS ALSO BEEN PROVIDED TO THE SECURITIES AND EXCHANGE COMMISSION. FIRST AMENDMENT TO PILOT MATERIALS TRANSFER AGREEMENT This is an amendment (“First Amendment”), effective as |
|
| October 6, 2016 |
Blueprint Exhibit 10.1 CONFIDENTIAL TREATMENT REQUESTED. INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND MARKED WITH “****” OR OTHERWISE CLEARLY INDICATED. AN UNREDACTED VERSION OF THIS DOCUMENT HAS ALSO BEEN PROVIDED TO THE SECURITIES AND EXCHANGE COMMISSION. PILOT MATERIALS TRANSFER AGREEMENT This Pilot Materials Transfer Agreement ("Agreement") is made and entered |
|
| September 9, 2016 |
COMMON STOCK PURCHASE WARRANT METASTAT, INC. ex4-1.htm Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTI |
|
| September 9, 2016 |
ex10-1.htm Exhibit 10.1 SUBSCRIPTION AGREEMENT This SUBSCRIPTION AGREEMENT (this ?Agreement?) is made and entered into as of [], 2016, by and among MetaStat, Inc., a Nevada corporation (the ?Company?), and each of the eligible investors who executes this Agreement and whose names are set forth on the signature pages hereto (individually, a ?Subscriber? and collectively, the ?Subscribers?). RECITAL |
|
| September 9, 2016 |
ex10-2.htm Exhibit 10.2 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this ?Agreement?) is made and entered into as of [], 2016, by and among MetaStat, Inc., a Nevada corporation (the ?Company?), and the subscribers signatory hereto (each, a ?Subscriber? and collectively, the ?Subscribers?). This Agreement is made pursuant to Subscription Agreement, dated on or about the date h |
|
| September 9, 2016 |
mtst8kaug312016.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 31, 2016 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 20-8753132 (C |
|
| September 7, 2016 |
mtst8kaug312016.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 31, 2016 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 20-8753132 (C |
|
| August 31, 2016 |
METASTAT, INC. AMENDMENT NO. 1 TO ORIGINAL ISSUE DISCOUNT PROMISSORY NOTE ex10-1.htm Exhibit 10.1 METASTAT, INC. AMENDMENT NO. 1 TO ORIGINAL ISSUE DISCOUNT PROMISSORY NOTE This Amendment No. 1 to Original Issue Discount Promissory Note (this ?Amendment?) is made effective as of August , 2016, by and among MetaStat, Inc., a Nevada corporation (the ?Company?) and (the ?Payee?). R E C I T A L S WHEREAS, the Payee and the Company are parties to that certain OID Note Purchas |
|
| August 31, 2016 |
mtst8kaug252016.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 25, 2016 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 20-8753132 (C |
|
| August 31, 2016 |
ex4-1.htm Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTI |
|
| July 14, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended May 31, 2016 OR [ ] TRANSITION REPORT UNDER SECTION 13 OF 15(d) OF THE EXCHANGE ACT OF 1934 From the transition period from to . Commission File Number 000-52735 METASTAT, INC. (Exact |
|
| July 7, 2016 |
PROSPECTUS METASTAT, INC. 1,773,568 shares of Common Stock mtst424b3july72016.htm Filed Pursuant to Rule 424(b)(3) Registration No. 333-203361 PROSPECTUS METASTAT, INC. 1,773,568 shares of Common Stock This prospectus relates to the resale, from time to time, of up to 1,773,568 shares of our common stock, par value $.0001 per share (the ?Common Stock?), being offered by the selling stockholders identified in this prospectus. The shares of Common Stock off |
|
| June 22, 2016 |
As filed with the Securities and Exchange Commission on June 22, 2016 As filed with the Securities and Exchange Commission on June 22, 2016 Registration No. |
|
| June 14, 2016 |
8-K 1 mtst8kjune82016.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 8, 2016 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 2 |
|
| May 31, 2016 |
U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (MARK ONE) [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended February 29, 2016 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission file number: 000-52735 METASTAT, INC. (Exa |
|
| May 31, 2016 |
Exhibit 4.15 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGIST |
|
| May 31, 2016 |
Exhibit 10.35 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this “Agreement”) is made and entered into as of May 26, 2016, by and among MetaStat, Inc., a Nevada corporation (the “Company”), and the subscribers signatory hereto (each, a “Subscriber” and collectively, the “Subscribers”). This Agreement is made pursuant to Subscription Agreement, dated on or about the date hereof, |
|
| May 31, 2016 |
Exhibit 10.34 SUBSCRIPTION AGREEMENT This SUBSCRIPTION AGREEMENT (this “Agreement”) is made and entered into by and among MetaStat, Inc., a Nevada corporation (the “Company”), and each of the eligible investors who executes this Agreement and whose names are set forth on the signature pages hereto (individually, a “Subscriber” and collectively, the “Subscribers”). RECITALS WHEREAS, the Company is |
|
| April 28, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 25, 2016 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 20-8753132 (Commission File Number |
|
| March 24, 2016 |
mtst8kmar212016.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 21, 2016 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 20-8753132 (Co |
|
| March 18, 2016 |
mtst8kmar152016.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 15, 2016 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 20-8753132 (Co |
|
| March 11, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 11, 2016 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 20-8753132 (Commission File Number |
|
| February 19, 2016 |
COMMON STOCK PURCHASE WARRANT METASTAT, INC. Warrant Shares: ______ Initial Exercise Date: ______ ex4-3.htm Exhibit 4.3 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTI |
|
| February 19, 2016 |
ex10-1.htm Exhibit 10.1 OID NOTE PURCHASE AGREEMENT This OID Note Purchase Agreement (this ?Agreement?) is made as of February 12, 2016 by and between MetaStat, Inc. (the ?Company?), a Nevada corporation, with offices at 27 Drydock Ave., 2nd Floor, Boston, MA 02210 and the purchasers identified on the signature pages hereto (the ?Purchasers?). WHEREAS, the Company desires to sell to the Purchasers |
|
| February 19, 2016 |
AMENDMENT NO. 1 TO PROMISSORY NOTE METASTAT, INC. ex4-2.htm Exhibit 4.2 AMENDMENT NO. 1 TO PROMISSORY NOTE OF METASTAT, INC. This Amendment No. 1 to promissory note (the ?Amendment?) is made as of February 12, 2016, by and between MetaStat, Inc., a Nevada corporation (the ?Company?), and Dolphin Offshore Partners, L.P. (the ?Payee?). Except as otherwise provided herein, capitalized terms used in this Amendment shall have the definitions set forth |
|
| February 19, 2016 |
mtst8kfeb192016.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 12, 2016 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 (Commission |
|
| February 19, 2016 |
METASTAT, INC. Original Issue Discount Promissory Note ex4-1.htm Exhibit 4.1 THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES LAWS AND MAY NOT BE SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS REGISTERED UNDER THE SECURITIES ACT AND UNDER APPLICABLE STATE SECURITIES LAWS OR UNLESS METASTAT, INC. SHALL HAVE RECEIVED AN OPINION OF COUNSEL THAT THE REGISTRATION OF SUCH SECUR |
|
| February 2, 2016 |
mtstfeb2016.htm METASTAT, INC. 27 Drydock Ave, 2nd Floor Boston, Massachusetts 02210 Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: MetaStat, Inc. Registration Statement on Form S-1 Initially Filed October 9, 2015 File No. 333-207380 Ladies and Gentlemen: MetaStat, Inc. (the "Registrant") previously filed the above-referenced regist |
|
| January 14, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 30, 2015 OR [ ] TRANSITION REPORT UNDER SECTION 13 OF 15(d) OF THE EXCHANGE ACT OF 1934 From the transition period from to . Commission File Number 000-52735 METASTAT, INC. (E |
|
| December 4, 2015 |
ex99-1.htm Exhibit 99.1 |
|
| December 4, 2015 |
MetaStat FORM 8-K (Current Report/Significant Event) mtst8kdec32015.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 4, 2015 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 (Commission F |
|
| November 23, 2015 |
MetaStat FORM 8-K (Current Report/Significant Event) mtst8knov192015.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 19, 2015 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 (Commission |
|
| November 23, 2015 |
AMENDED AND RESTATED BYLAWS METASTAT, INC. (a Nevada corporation) ARTICLE I ex3-1.htm Exhibit 3.1 AMENDED AND RESTATED BYLAWS OF METASTAT, INC. (a Nevada corporation) ARTICLE I STOCKHOLDERS 1. CERTIFICATES REPRESENTING STOCK. Every holder of shares in the corporation shall be entitled to have a certificate signed in the name of the corporation by the chairman or vice chairman of the board or the president or a vice president, and by the chief financial officer or an assis |
|
| November 18, 2015 |
As filed with the Securities and Exchange Commission on November 18, 2015 Registration No. |
|
| October 15, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended August 31, 2015 OR [ ] TRANSITION REPORT UNDER SECTION 13 OF 15(d) OF THE EXCHANGE ACT OF 1934 From the transition period from to . Commission File Number 000-52735 METASTAT, INC. (Exa |
|
| October 9, 2015 |
As filed with the Securities and Exchange Commission on October 9, 2015 Registration No. |
|
| October 8, 2015 |
ex99-1.htm Exhibit 99.1 MetaStat Announces Reverse Stock Split in Preparation for a Proposed Uplisting to a National Market MetaStat takes action to enact a 1-for-15 reverse stock split as the next step in the process of uplisting its stock on a national securities exchange BOSTON ? October 7, 2015 ? MetaStat, Inc. (OTCQB: MTST), a molecular diagnostic company, today announced that effective 7:00 |
|
| October 8, 2015 |
MetaStat FORM 8-K (Current Report/Significant Event) mtst8koct82015.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 8, 2015 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 (Commission Fi |
|
| October 1, 2015 |
MTST / MetaStat, Inc. / Yeshiva University - METASTAT, INC. SC 13D/A Activist Investment SC 13D/A 1 a51192307.htm METASTAT, INC. SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Amendment No. 1)* Under the Securities Exchange Act of 1934 METASTAT, INC. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 59140A104 (CUSIP Number) Yeshiva University c/o Office of the General Counsel 500 West 185th Street, |
|
| September 9, 2015 |
MetaStat 8-K (Current Report/Significant Event) mtst8ksep92015.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): September 9, 2015 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 20-8753132 ( |
|
| September 9, 2015 |
ex99-1.htm |
|
| August 5, 2015 |
COMMON STOCK PURCHASE WARRANT METASTAT, INC. exb.htm Exhibit 4.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE |
|
| August 5, 2015 |
note.htm Exhibit 10.1 NOTE PURCHASE AGREEMENT This Note Purchase Agreement (this ?Agreement?) is made as of July [], 2015 by and between MetaStat, Inc. (the ?Company?), a Nevada corporation, with offices at 27 Drydock Ave., 2nd Floor, Boston MA 02210 and the purchasers identified on the signature pages hereto (the ?Purchasers?). WHEREAS, the Company desires to sell to the Purchasers, and the Purch |
|
| August 5, 2015 |
COMMON STOCK PURCHASE WARRANT METASTAT, INC. exc.htm Exhibit 4.3 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE |
|
| August 5, 2015 |
METASTAT, INC. Promissory Note exa.htm Exhibit 4.1 THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES LAWS AND MAY NOT BE SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS REGISTERED UNDER THE SECURITIES ACT AND UNDER APPLICABLE STATE SECURITIES LAWS OR UNLESS METASTAT, INC. SHALL HAVE RECEIVED AN OPINION OF COUNSEL THAT THE REGISTRATION OF SUCH SECURIT |
|
| August 5, 2015 |
ex99-1.htm Exhibit 99.1 MetaStat Raises Additional Capital in Private Placement Company Completes Note Offering of $1.2 Million BOSTON- MetaStat, Inc. (OTCQB:MTST), a molecular diagnostic company developing and commercializing epigenetic diagnostic tests for early and reliable prediction of systemic cancer metastasis, announced effective July 31, 2015 the closing of a private placement of promisso |
|
| August 5, 2015 |
MetaStat FORM 8-K (Current Report/Significant Event) mtst8kjuly312015.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): July 31, 2015 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 (Commission Fi |
|
| July 29, 2015 |
Filed pursuant to Rule 424(b)(3) mtst424b3july2015.htm Filed pursuant to Rule 424(b)(3) Registration No. 333-203361 PROSPECTUS METASTAT, INC. 27,490,507 shares of Common Stock This prospectus relates to the resale, from time to time, of up to 27,490,507 shares of our common stock, par value $.0001 per share (the ?Common Stock?), being offered by the selling stockholders identified in this prospectus. The shares of Common Stock of |
|
| July 28, 2015 |
mtstcorrespjuly282015.htm July 28, 2015 Securities and Exchange Commission 450 Fifth Street, N.W. Washington, D.C. 20549 Re: MetaStat, Inc. Registration Statement on Form S-1 (the ?Registration Statement?) File No. 333- 203361 Ladies and Gentlemen: MetaStat, Inc. (the ?Company?) hereby requests that the effective date of the above-captioned Registration Statement be accelerated to 4:00 p.m. on Jul |
|
| July 28, 2015 |
mtstcorrespjuly282015.htm July 28, 2015 Securities and Exchange Commission 450 Fifth Street, N.W. Washington, D.C. 20549 Re: MetaStat, Inc. Registration Statement on Form S-1 (the ?Registration Statement?) File No. 333- 203361 Ladies and Gentlemen: MetaStat, Inc. (the ?Company?) hereby requests that the effective date of the above-captioned Registration Statement be accelerated to 4:00 p.m. on Jul |
|
| July 27, 2015 |
correspondence.htm METASTAT, INC. 27 DryDock Ave, 2nd Floor Boston, MA 02210 July 27, 2015 Kate Maher, Esq. Securities and Exchange Commission 100 F. Street, N.E. Washington, D.C. 20549 Re: MetaStat, Inc. Amendment No. 3 to Registration Statement on Form S-1 Filed July 17, 2015 File No. 333-203361 Dear Ms. Maher: On behalf of MetaStat, Inc., a Nevada corporation (the ?Company?), we hereby provide |
|
| July 27, 2015 |
As filed with the Securities and Exchange Commission on July 27, 2015 As filed with the Securities and Exchange Commission on July 27, 2015 Registration No. |
|
| July 17, 2015 |
As filed with the Securities and Exchange Commission on July 17, 2015 As filed with the Securities and Exchange Commission on July 17, 2015 Registration No. |
|
| July 17, 2015 |
mtstcorrespjul172015.htm METASTAT, INC. 27 DryDock Ave, 2nd Floor Boston, MA 02210 July 17, 2015 Kate Maher, Esq. Securities and Exchange Commission 100 F. Street, N.E. Washington, D.C. 20549 Re: MetaStat, Inc. Amendment No. 2 to Registration Statement on Form S-1 Filed June 24, 2015 File No. 333-203361 Dear Ms. Maher: On behalf of MetaStat, Inc., a Nevada corporation (the ?Company?), we hereby pr |
|
| July 15, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended May 31, 2015 OR [ ] TRANSITION REPORT UNDER SECTION 13 OF 15(d) OF THE EXCHANGE ACT OF 1934 From the transition period from to . Commission File Number 000-52735 METASTAT, INC. (Exact |
|
| June 24, 2015 |
ex10-1.htm Exhibit 10.1 ASET Therapeutics, LLC 1350 Treat Blvd. Suite 400 Walnut Creek, CA 94597 Effective as of May 31, 2015 Douglas Hamilton Chief Executive Officer MetaStat, Inc. 27 Drydock Avenue 2nd Floor Boston, MA 02210 Re: Letter of clarification re: Memorandum of Understanding between MetaStat, Inc. and ASET Therapeutics, LLC Dear Doug: Reference is hereby made to that certain Memorandum |
|
| June 24, 2015 |
PROMISSORY NOTE $150,000 May 31, 2015 ex4-1.htm Exhibit 4.1 PROMISSORY NOTE $150,000 May 31, 2015 1. Principal. This promissory note (the ?Note?) evidences the agreement by ASET Therapeutics, LLC, a Delaware limited liability company (the ?Maker?), to pay to MetaStat, Inc., a Nevada corporation (?Payee?) on or before the dates set forth below (the ?Maturity Date?), at the address designated in Section 6 hereof, or at such other place |
|
| June 24, 2015 |
MetaStat FORM 8-K (Current Report/Significant Event) mtst8kjune2015.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 22, 2015 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 20-8753132 (Comm |
|
| June 24, 2015 |
As filed with the Securities and Exchange Commission on June 24 , 2015 As filed with the Securities and Exchange Commission on June 24 , 2015 Registration No. |
|
| June 24, 2015 |
PROMISSORY NOTE $75,000 May 31, 2015 ex4-2.htm Exhibit 4.2 PROMISSORY NOTE $75,000 May 31, 2015 1. Principal. This promissory note (the ?Note?) evidences the agreement by ASET Therapeutics, LLC, a Delaware limited liability company (the ?Maker?), to pay to MetaStat, Inc., a Nevada corporation (?Payee?) on or before the dates set forth below (the ?Maturity Date?), at the address designated in Section 6 hereof, or at such other place a |
|
| June 23, 2015 |
mtstcorresp.htm METASTAT, INC. 27 DryDock Ave, 2nd Floor Boston, MA 02210 June 23, 2015 Kate Maher, Esq. Securities and Exchange Commission 100 F. Street, N.E. Washington, D.C. 20549 Re: MetaStat, Inc. Amendment No. 1 to Registration Statement on Form S-1 Filed June 1, 2015 File No. 333-203361 Dear Ms. Maher: On behalf of MetaStat, Inc., a Nevada corporation (the ?Company?), we hereby provide a re |
|
| June 23, 2015 |
MetaStat FORM 8-K (Current Report/Significant Event) mtst8kjune220215.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 22, 2015 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 20-8753132 (Co |
|
| June 18, 2015 |
ex10-3.htm Exhibit 10.3 CONSULTING AGREEMENT This Consulting Agreement (the ?Agreement?) is made as of the 17th day of June 2015, by and between MetaStat, Inc., a Nevada corporation with its principal place of business located at 27 Drydock Ave, Boston, MA 02210 (the ?Company?), and Oscar Bronsther, with his principal place of business located at 11500 Dahlia Terrace, Potomac, Maryland 20854 (the |
|
| June 18, 2015 |
METASTAT, INC. EMPLOYMENT AGREEMENT ex10-1.htm Exhibit 10.1 METASTAT, INC. EMPLOYMENT AGREEMENT This Employment Agreement (this ?Agreement?) is made and entered into on June 17, 2015 (the ?Effective Date?) by and between MetaStat, Inc. (the ?Company?) and Douglas Hamilton (?Executive?). The Company and Executive are hereinafter collectively referred to as the ?Parties?, and individually referred to as a ?Party?. Recitals A. The Comp |
|
| June 18, 2015 |
MetaStat FORM 8-K (Current Report/Significant Event) mtst8kjune182015.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 17, 2015 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 (Commission Fi |
|
| June 18, 2015 |
SEPARATION AND RELEASE AGREEMENT ex10-2.htm Exhibit 10.2 SEPARATION AND RELEASE AGREEMENT This SEPARATION AND RELEASE AGREEMENT (the ?Agreement?) is made and entered into this 17th day of June, 2015 by and between Oscar Bronsther, M.D. (?Bronsther?) and MetaStat, Inc., a Nevada corporation (the ?Company?). WHEREAS, Bronsther has been employed by the Company as its Chief Executive Officer and Chief Medical Officer; WHEREAS, Bronst |
|
| June 18, 2015 |
ex99-1.htm Exhibit 99.1 MetaStat, Inc. Announces Douglas A. Hamilton Named President, Chief Executive Officer Oscar L. Bronsther, M.D. Assumes New Role, Chairman of Scientific and Clinical Advisory Board BOSTON ? June 18, 2015 ? MetaStat, Inc. (OTCQB: MTST), announced that Douglas A. Hamilton has been elected as President and Chief Executive Officer of the company. Mr. Hamilton has consulted for t |
|
| June 1, 2015 |
As filed with the Securities and Exchange Commission on June 1, 2015 As filed with the Securities and Exchange Commission on June 1, 2015 Registration No. |
|
| June 1, 2015 |
METASTAT, INC. 27 DryDock Ave, 2nd Floor Boston, MA 02210 METASTAT, INC. 27 DryDock Ave, 2nd Floor Boston, MA 02210 June 1, 2015 Kate Maher, Esq. Securities and Exchange Commission 100 F. Street, N.E. Washington, D.C. 20549 Re: MetaStat, Inc. Registration Statement on Form S-1 Filed April 10, 2015 File No. 333-203361 Dear Ms. Maher: On behalf of MetaStat, Inc., a Nevada corporation (the “Company”), we hereby provide a response to the comments issued in a |
|
| May 29, 2015 |
MetaStat DEFINITIVE SCHEDULE 14A mtstdef14ajune222015.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant T Filed by a party other than the Registrant o Check the appropriate box: o Preliminary proxy statement o |
|
| May 28, 2015 |
U.S. SECURITIES AND EXCHANGE COMMISSION U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (MARK ONE) [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended February 28, 2015 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission file number: 000-52735 METASTAT, INC. (Exa |
|
| May 21, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 16, 2015 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 20-8753132 (Commission File Number) |
|
| May 12, 2015 |
MetaStat PRELIMINARY SCHEDULE 14A mtstpre14ajune222015.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant T Filed by a party other than the Registrant o Check the appropriate box: T Preliminary proxy statement o |
|
| April 10, 2015 |
As filed with the Securities and Exchange Commission on April 10, 2015 As filed with the Securities and Exchange Commission on April 10, 2015 Registration No. |
|
| April 10, 2015 |
Exhibit 10.22 CONSULTING AGREEMENT This Consulting Agreement (the ?Agreement?) is made as of the 1st day of August, 2014, by and between MetaStat, Inc., a Nevada corporation with its principal place of business located at (the ?Company?) and New Biology Ventures, LLC with its principal place of business located at (the ?NBV?). RECITALS WHEREAS, NBV has agreed to make the services of Douglas Hamilt |
|
| April 6, 2015 |
MetaStat FORM 8-K (Current Report/Significant Event) mtst8kmar312015.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 31, 2015 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 20-8753132 (Co |
|
| April 2, 2015 |
AMENDED AND RESTATED SERIES A COMMON STOCK PURCHASE WARRANT METASTAT, INC. seriesa.htm NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
| April 2, 2015 |
ex99-1.htm Exhibit 99.1 MetaStat Announces Closing of Series B Private Placement Company Raises Total Gross Proceeds of $3.4 Million BOSTON- MetaStat, Inc. (OTCQB:MTST), a molecular diagnostic company focused on developing and commercializing epigenetic-based diagnostic tests for early and reliable prediction of systemic metastasis, announced today the final closing of its Series B Preferred Stock |
|
| April 2, 2015 |
MetaStat FORM 8-K (Current Report/Significant Event) mtst8kapr12015.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 27, 2015 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 20-8753132 (Com |
|
| April 2, 2015 |
AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT rightsandagree.htm AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT This Amended and Restated Registration Rights Agreement (this “Agreement”) is made and entered into as of March 27, 2015, by and among MetaStat, Inc., a Nevada corporation (the “Company”), and the purchasers signatory hereto (each, a “Purchaser” and collectively, the “Purchasers”). This Agreement is made pursuant to the Amended |
|
| April 2, 2015 |
AMENDED AND RESTATED SECURITIES PURCHASE AGREEMENT purchaseagree.htm AMENDED AND RESTATED SECURITIES PURCHASE AGREEMENT This AMENDED AND RESTATED SECURITIES PURCHASE AGREEMENT (this ?Agreement?) is dated as of March 27, 2015 by and among MetaStat, Inc., a Nevada corporation (the ?Company?), and each of the Purchasers whose names are set forth on the signature pages hereto (individually, a ?Purchaser? and collectively, the ?Purchasers?). RECITALS W |
|
| April 2, 2015 |
serieb.htm METASTAT, INC. FIRST AMENDED AND RESTATED CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES B CONVERTIBLE PREFERRED STOCK The undersigned, the Chief Executive Officer of MetaStat, Inc., a Nevada corporation (the ?Corporation?), in accordance with the provisions of the Nevada Revised Statutes, does hereby certify: That pursuant to the authority conferred upon th |
|
| February 26, 2015 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 25, 2015 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 20-8753132 (Commission File Num |
|
| February 26, 2015 |
Exhibit 99.1 |
|
| January 14, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 30, 2014 OR [ ] TRANSITION REPORT UNDER SECTION 13 OF 15(d) OF THE EXCHANGE ACT OF 1934 From the transition period from to . Commission File Number 000-52735 METASTAT, INC. (E |
|
| January 13, 2015 |
CONFIDENTIAL TREATMENT REQUESTED. Exhibit 10.1 CONFIDENTIAL TREATMENT REQUESTED. INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND MARKED WITH “****” OR OTHERWISE CLEARLY INDICATED. AN UNREDACTED VERSION OF THIS DOCUMENT HAS ALSO BEEN PROVIDED TO THE SECURITIES AND EXCHANGE COMMISSION. LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT by and between METASTAT, INC., METASTAT BIOMEDICAL, INC. and ASET |
|
| January 13, 2015 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 25, 2014 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 20-8753132 (Commission File N |
|
| January 12, 2015 |
MTST / MetaStat, Inc. / DOLPHIN OFFSHORE PARTNERS LP - SC 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* MetaStat, Inc (Name of Issuer) Common Stock, $0.001 par value per share (Title of Class of Securities) 000 1404943 (CUSIP Number) Peter E. Salas P.O. Box 16867 Fernandina Beach, Florida 32034 phone 904 491 5003 (Name, Address and Telephone Number of Perso |
|
| January 7, 2015 |
SERIES B COMMON STOCK PURCHASE WARRANT METASTAT, INC. Exhibit 4.3 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
| January 7, 2015 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of December 31, 2014 by and among MetaStat, Inc., a Nevada corporation (the “Company”), and each of the Purchasers whose names are set forth on the signature pages hereto (individually, a “Purchaser” and collectively, the “Purchasers”). RECITALS WHEREAS, the Company and the Purchasers are e |
|
| January 7, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 31, 2014 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 20-8753132 (Commission File Num |
|
| January 7, 2015 |
Exhibit 4.1 METASTAT, INC. CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES B CONVERTIBLE PREFERRED STOCK WHEREAS, the Articles of Incorporation of MetaStat, Inc., a Nevada corporation (the “Corporation”) provides for a class of its authorized stock known as Preferred Stock, comprised of 10,000,000 shares, issuable from time to time in one or more series; WHEREAS, the Bo |
|
| January 7, 2015 |
MetaStat Closes First Round of a $3.5 Million Private Placement Exhibit 99.1 MetaStat Closes First Round of a $3.5 Million Private Placement BOSTON – January 6, 2015 – MetaStat, Inc. (OTCQB: MTST), a molecular diagnostic company focused on developing and commercializing epigenetic-based diagnostic tests for early and reliable prediction of systemic metastasis, has consummated an initial closing of $1.3 million in a private placement of up to $3.5 million of sh |
|
| January 7, 2015 |
Exhibit 10.2 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this “Agreement”) is made and entered into as of December 31, 2014, by and among MetaStat, Inc., a Nevada corporation (the “Company”), and the purchasers signatory hereto (each, a “Purchaser” and collectively, the “Purchasers”). This Agreement is made pursuant to the Securities Purchase Agreement, dated as of the date h |
|
| January 7, 2015 |
SERIES A COMMON STOCK PURCHASE WARRANT METASTAT, INC. Exhibit 4.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
| December 2, 2014 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 25, 2014 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 20-8753132 (Commission File Num |
|
| December 2, 2014 |
Exhibit 99.1 MetaStat Completes Divestiture of Its Therapeutic Assets Becomes Pure-Play Molecular Diagnostics Company, Focused Exclusively on Developing and Commercializing Epigenetic-based Diagnostic Tests to Determine the Risk of Developing Systemic Metastasis BOSTON – December 2, 2014 - MetaStat, Inc. (OTCQB:MTST), a molecular diagnostic company focused on developing and commercializing epigene |
|
| October 30, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 24, 2014 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 20-8753132 (Commission File Numb |
|
| October 30, 2014 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of October 24, 2014 by and among MetaStat, Inc., a Nevada corporation (the “Company”), and each of the Purchasers whose names are set forth on the signature pages hereto (individually, a “Purchaser” and collectively, the “Purchasers”). RECITALS WHEREAS, the Company and the Purchasers are ex |
|
| October 20, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 14, 2014 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 (Commission File Number) 20-8753 |
|
| October 15, 2014 |
MTST / MetaStat, Inc. / Mkm Opportunity Master Fund Ltd - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* METASTAT, INC. (Name of Issuer) Common Stock, par value $.0001 (Title of Class of Securities) 59140A104 (CUSIP Number) David Skriloff c/o MKM Capital Advisors, LLC 1410 Broadway, 23rd Floor New York, NY 10018 212-677-9026 (Name, Address and Telephone Num |
|
| October 15, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended August 31, 2014 OR [ ] TRANSITION REPORT UNDER SECTION 13 OF 15(d) OF THE EXCHANGE ACT OF 1934 From the transition period from to . Commission File Number 000-52735 METASTAT, INC. (Exa |
|
| October 15, 2014 |
EXHIBIT 99.1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including any and all amendments thereto) with respect to the Common Stock, par value $0.0001 per share, of Metastat Inc., a Nevada corporation, and further agree that this Joi |
|
| October 15, 2014 |
AMENDMENT NO. 1 TO MEMORANDUM OF UNDERSTANDING Exhibit 10.1 AMENDMENT NO. 1 TO MEMORANDUM OF UNDERSTANDING THIS AMENDMENT NO. 1 TO MEMORANDUM OF UNDERSTANDING (this “Amendment”), dated as of October 12, 2014, is made by MetaStat, Inc., a Nevada corporation (“MetaStat” or the “Licensor”), MetaStat BioMedical, Inc., a Delaware corporation and a wholly-owned subsidiary of MetaStat (the “Subsidiary”), and Northstar Beacon, LLC, a Delaware limited |
|
| October 14, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 10, 2014 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 20-8753132 (Commission File Numb |
|
| October 14, 2014 |
Exhibit 10.1 Execution Copy PURCHASE AGREEMENT PURCHASE AGREEMENT (the “Agreement”), dated as of October 10, 2014, by and between METASTAT, INC., a Nevada corporation (the “Company”), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (the “Investor”). WHEREAS: Subject to the terms and conditions set forth in this Agreement, the Company wishes to sell to the Investor, and th |
|
| October 14, 2014 |
Exhibit 10.2 Execution Copy REGISTRATION RIGHTS AGREEMENT REGISTRATION RIGHTS AGREEMENT (this "Agreement"), dated as of October 10, 2014, by and between METASTAT, INC., a Nevada corporation (the "Company"), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (together with it permitted assigns, the “Buyer”). Capitalized terms used herein and not otherwise defined herein shall |
|
| September 10, 2014 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): September 10, 2014 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 (Commission File Number) 20-87 |
|
| September 10, 2014 |
Exhibit 99.1 |
|
| September 5, 2014 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT (Amendment No. 5 ) Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 7, 2013 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 20-8753132 (C |
|
| July 23, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): July 22, 2014 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 20-8753132 (Commission File Number) |
|
| July 23, 2014 |
Exhibit 10.16 CONFIDENTIAL TREATMENT REQUESTED. INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND MARKED WITH “****” OR OTHERWISE CLEARLY INDICATED. AN UNREDACTED VERSION OF THIS DOCUMENT HAS ALSO BEEN PROVIDED TO THE SECURITIES AND EXCHANGE COMMISSION. MASSACHUSETTS INSTITUTE OF TECHNOLOGY EXCLUSIVE PATENT LICENSE AGREEMENT -1- TABLE OF CONTENTS RECITALS 3 1. Definiti |
|
| July 23, 2014 |
Exhibit 10.17 CONFIDENTIAL TREATMENT REQUESTED. INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND MARKED WITH “****” OR OTHERWISE CLEARLY INDICATED. AN UNREDACTED VERSION OF THIS DOCUMENT HAS ALSO BEEN PROVIDED TO THE SECURITIES AND EXCHANGE COMMISSION. MASSACHUSETTS INSTITUTE OF TECHNOLOGY EXCLUSIVE PATENT LICENSE AGREEMENT -1- TABLE OF CONTENTS RECITALS 3 1. Definiti |
|
| July 23, 2014 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT (Amendment No. 4 ) Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 7, 2013 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 20-8753132 (C |
|
| July 17, 2014 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): July 14, 2014 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 20-8753132 (Commission File Number) |
|
| July 17, 2014 |
MetaStat, Inc. Announces Memorandum of Understanding to Transfer its Therapeutic Business Exhibit 99.1 MetaStat, Inc. Announces Memorandum of Understanding to Transfer its Therapeutic Business MONTCLAIR, NJ. / PR Newswire / July 17, 2014 – MetaStat, Inc. (OTCQB: MTST), a life science company focused on understanding and treating systemic metastasis, announced today that on July 14, 2014 it entered into a binding Memorandum of Understanding (MOU) to transfer its therapeutic assets to a |
|
| July 17, 2014 |
Exhibit 10.18 MEMORANDUM OF UNDERSTANDING This binding Memorandum of Understanding (“MOU”), dated as of July 14, 2014, by and among MetaStat, Inc., a Nevada corporation with offices at 8 Hillside Drive, Suite 207, Montclair, New Jersey (“MetaStat” or the “Licensor”), MetaStat BioMedical, Inc., a Delaware corporation and a wholly-owned subsidiary of MetaStat (the “Subsidiary”), and Northstar Beacon |
|
| July 15, 2014 |
Exhibit 10.18 MASSACHUSETTS INSTITUTE OF TECHNOLOGY and COMPANY TANGIBLE PROPERTY LICENSE AGREEMENT TABLE OF CONTENTS R E C I T A L S 1 1. Definitions. 2 2. Grant of Rights. 6 3. COMPANY Diligence Obligations. 8 4. Royalties and Payment Terms. 8 5. Reports and Records. 11 6. Indemnification and Insurance. 12 7. No Representations or Warranties. 13 8. Assignment. 14 9. General Compliance with Laws |
|
| July 15, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended May 31, 2014 OR [ ] TRANSITION REPORT UNDER SECTION 13 OF 15(d) OF THE EXCHANGE ACT OF 1934 From the transition period from to . Commission File Number 000-52735 METASTAT, INC. (Exact |
|
| July 2, 2014 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of June 30, 2014 by and among MetaStat, Inc., a Nevada corporation (the “Company”), and each of the Purchasers whose names are set forth on the signature pages hereto (individually, a “Purchaser” and collectively, the “Purchasers”). RECITALS WHEREAS, the Company and the Purchasers are execu |
|
| July 2, 2014 |
Exhibit 10.2 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this “Agreement”) is made and entered into as of June 30, 2014, by and among MetaStat, Inc., a Nevada corporation (the “Company”), and the purchasers signatory hereto (each, a “Purchaser” and collectively, the “Purchasers”). This Agreement is made pursuant to the Securities Purchase Agreement, dated as of the date hereo |
|
| July 2, 2014 |
COMMON STOCK PURCHASE WARRANT METASTAT, INC. Exhibit 4.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
| July 2, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 30, 2014 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 20-8753132 (Commission File Number) |
|
| July 2, 2014 |
MetaStat, Inc. Closes Equity Financing Exhibit 99.1 MetaStat, Inc. Closes Equity Financing MONTCLAIR, NJ. ACCESSWIRE/ July 2, 2014 – MetaStat, Inc. (OTCQB: MTST), a life science company focused on understanding and treating systemic metastasis, announced today that on June 30, 2014, it entered into a securities purchase agreement in a private placement totaling $5.7 million, inclusive of the automatic exchange of outstanding convertibl |
|
| July 2, 2014 |
Exhibit 4.1 METASTAT, INC. CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES A CONVERTIBLE PREFERRED STOCK WHEREAS, the Articles of Incorporation of MetaStat, Inc., a Nevada corporation (the “Corporation”) provides for a class of its authorized stock known as preferred stock, comprised of 10,000,000 shares, issuable from time to time in one or more series; WHEREAS, the Bo |
|
| July 1, 2014 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT (Amendment No. 3) Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 7, 2013 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 20-8753132 (Co |
|
| June 13, 2014 |
METASTAT, INC. May 2014 Convertible Promissory Note Exhibit 4.4 THIS NOTE AND THE SECURITIES INTO WHICH IT IS CONVERTIBLE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES LAWS AND MAY NOT BE SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS REGISTERED UNDER THE SECURITIES ACT AND UNDER APPLICABLE STATE SECURITIES LAWS OR UNLESS METASTAT, INC. SHALL HAVE RECEIVED AN OPINION OF COUN |
|
| June 13, 2014 |
MAY 2014 CONVERTIBLE NOTE AND WARRANT PURCHASE AGREEMENT Exhibit 10.15 MAY 2014 CONVERTIBLE NOTE AND WARRANT PURCHASE AGREEMENT This May 2014 Convertible Note and Warrant Purchase Agreement, dated as of , 2014 (this “Agreement”), is entered into by and among MetaStat, Inc., a Nevada corporation (the “Company”), and the other signatories hereto (each a “Lender” and collectively, the “Lenders”). RECITALS A. On the terms and subject to the conditions set f |
|
| June 13, 2014 |
COMMON STOCK PURCHASE WARRANT METASTAT, INC. Exhibit 4.5 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
| June 13, 2014 |
U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (MARK ONE) [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended February 28, 2014 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission file number: 000-52735 METASTAT, INC. (Exa |
|
| June 12, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1) (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended May 31, 2013 OR [ ] TRANSITION REPORT UNDER SECTION 13 OF 15(d) OF THE EXCHANGE ACT OF 1934 From the transition period from to . Commission File Number 000-52735 ME |
|
| June 12, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1) (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended August 31, 2013 OR [ ] TRANSITION REPORT UNDER SECTION 13 OF 15(d) OF THE EXCHANGE ACT OF 1934 From the transition period from to . Commission File Number 000-52735 |
|
| June 12, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No.1) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No.1) (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 30, 2013 OR [ ] TRANSITION REPORT UNDER SECTION 13 OF 15(d) OF THE EXCHANGE ACT OF 1934 From the transition period from to . Commission File Number 000-5273 |
|
| May 29, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 28, 2014 Commission File Number: 000-52735 MetaStat, Inc. |
|
| May 28, 2014 |
- THIS IS A NT 10-K ATTACHMENT FILE IN HTM FORMAT. OMB APPROVAL OMB Number: 3235-0058 Expires: August 31, 2015 Estimated average burden hours per response . |
|
| April 11, 2014 |
Exhibit 10.16 CONFIDENTIAL TREATMENT REQUESTED. INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND MARKED WITH “****” OR OTHERWISE CLEARLY INDICATED. AN UNREDACTED VERSION OF THIS DOCUMENT HAS ALSO BEEN PROVIDED TO THE SECURITIES AND EXCHANGE COMMISSION. MASSACHUSETTS INSTITUTE OF TECHNOLOGY EXCLUSIVE PATENT LICENSE AGREEMENT -1- TABLE OF CONTENTS RECITALS 3 1. Definiti |
|
| April 11, 2014 |
Exhibit 10.17 CONFIDENTIAL TREATMENT REQUESTED. INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND MARKED WITH “****” OR OTHERWISE CLEARLY INDICATED. AN UNREDACTED VERSION OF THIS DOCUMENT HAS ALSO BEEN PROVIDED TO THE SECURITIES AND EXCHANGE COMMISSION. MASSACHUSETTS INSTITUTE OF TECHNOLOGY EXCLUSIVE PATENT LICENSE AGREEMENT -1- TABLE OF CONTENTS RECITALS 3 1. Definiti |
|
| April 11, 2014 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits - FORM 8-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT (Amendment No. 2) Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 7, 2013 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 20-8753132 (Co |
|
| March 13, 2014 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant - UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 7, 2014 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 20-8753132 (Commission File Number) |
|
| March 13, 2014 |
Exhibit 16.1 13 March 2014 Office of the Chief Accountant Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 We have read Item 4.01 included in the Form 8-K dated March 13, 2014 of MetaStat, Inc. to be filed with the Securities and Exchange Commission and are in agreement with the statements related to our firm. Sincerely, /s/ Malone Bailey, LLP MaloneBailey, LLP Houston, |
|
| March 6, 2014 |
Financial Statements and Exhibits, Other Events - UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 6, 2014 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 20-8753132 (Commission File Number) |
|
| March 6, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 28, 2014 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 20-8753132 (Commission File Num |
|
| March 6, 2014 |
AMENDMENT NO. 1 TO ADDITIONAL 2014 CONVERTIBLE PROMISSORY NOTE METASTAT, INC. Exhibit 4.3 AMENDMENT NO. 1 TO ADDITIONAL 2014 CONVERTIBLE PROMISSORY NOTE OF METASTAT, INC. THIS AMENDMENT NO. 1 TO ADDITIONAL 2014 CONVERTIBLE PROMISSORY NOTE OF METASTAT, INC. (this “Amendment”), dated as of February , 2014, is made by MetaStat, Inc., a Nevada corporation (the “Company”), and the undersigned payee (the “Payee” and, together with the Company, are sometimes referred to individual |
|
| March 6, 2014 |
MetaStat, Inc. Announces Issuance of New U.S. Patent for its MetaSite MetaStat, Inc. Announces Issuance of New U.S. Patent for its MetaSite Breast™ Test MONTCLAIR, N.J., March 6, 2014 - MetaStat, Inc. (MTST), a life science company focused on understanding and treating systemic metastasis, announced today that the United States Patent and Trademark Office (USPTO) issued on February 4, 2014, U.S. Patent No. 8,642,277 entitled: "TUMOR MICROENVIRONMENT OF METASTASIS (T |
|
| March 6, 2014 |
AMENDMENT NO. 1 TO ADDITIONAL 2014 CONVERTIBLE NOTE AND WARRANT PURCHASE AGREEMENT METASTAT, INC. Exhibit 10.2 AMENDMENT NO. 1 TO ADDITIONAL 2014 CONVERTIBLE NOTE AND WARRANT PURCHASE AGREEMENT OF METASTAT, INC. THIS AMENDMENT NO. 1 TO ADDITIONAL 2014 CONVERTIBLE NOTE AND WARRANT PURCHASE AGREEMENT OF METASTAT, INC. (this “Amendment”), dated as of February , 2014, is made by MetaStat, Inc., a Nevada corporation (the “Company”), and the undersigned lender (the “Lender” and, together with the Co |
|
| February 10, 2014 |
MetaStat, Inc. Launches Scientific Advisory Board for Therapeutics Exhibit 99.1 MetaStat, Inc. Launches Scientific Advisory Board for Therapeutics MONTCLAIR, NJ– February 10, 2014 - MetaStat, Inc. (OTCQB: MTST), a life science company focused on understanding and treating systemic metastasis, today announced the appointments of scientific and clinical leaders from the fields of RNA biology, alternative splicing, and therapeutic resistance in cancer to its newly f |
|
| February 10, 2014 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 4, 2014 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 20-8753132 (Commission File Numb |
|
| February 6, 2014 |
Exhibit 10.17 CONFIDENTIAL TREATMENT REQUESTED. INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND MARKED WITH “****” OR OTHERWISE CLEARLY INDICATED. AN UNREDACTED VERSION OF THIS DOCUMENT HAS ALSO BEEN PROVIDED TO THE SECURITIES AND EXCHANGE COMMISSION. MASSACHUSETTS INSTITUTE OF TECHNOLOGY EXCLUSIVE PATENT LICENSE AGREEMENT -1- TABLE OF CONTENTS RECITALS 3 1. Definiti |
|
| February 6, 2014 |
Exhibit 10.16 CONFIDENTIAL TREATMENT REQUESTED. INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND MARKED WITH “****” OR OTHERWISE CLEARLY INDICATED. AN UNREDACTED VERSION OF THIS DOCUMENT HAS ALSO BEEN PROVIDED TO THE SECURITIES AND EXCHANGE COMMISSION. MASSACHUSETTS INSTITUTE OF TECHNOLOGY EXCLUSIVE PATENT LICENSE AGREEMENT -1- TABLE OF CONTENTS RECITALS 3 1. Definiti |
|
| February 6, 2014 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits - FORM 8-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT (Amendment No. 1) Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 7, 2013 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 20-8753132 (Co |
|
| January 21, 2014 |
THIS NOTE AND THE SECURITIES INTO WHICH IT IS CONVERTIBLE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES LAWS AND MAY NOT BE SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS REGISTERED UNDER THE SECURITIES ACT AND UNDER APPLICABLE STATE SECURITIES LAWS OR UNLESS METASTAT, INC. |
|
| January 21, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 14, 2014 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 20-8753132 (Commission File Numb |
|
| January 21, 2014 |
ADDITIONAL 2014 CONVERTIBLE NOTE AND WARRANT PURCHASE AGREEMENT ADDITIONAL 2014 CONVERTIBLE NOTE AND WARRANT PURCHASE AGREEMENT This Additional 2014 Convertible Note and Warrant Purchase Agreement, dated as of January , 2014 (this “Agreement”), is entered into by and among MetaStat, Inc. |
|
| January 21, 2014 |
COMMON STOCK PURCHASE WARRANT METASTAT, INC. NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEM |
|
| January 21, 2014 |
METASTAT, INC. AMENDMENT NO. 1 TO CONVERTIBLE PROMISSORY NOTE METASTAT, INC. AMENDMENT NO. 1 TO CONVERTIBLE PROMISSORY NOTE This Amendment No. 1 to Convertible Promissory Note (the “Amendment”) is made as of December 31, 2013, by and among MetaStat, Inc., a Nevada corporation (the “Company”) and (the “Payee”). RECITALS WHEREAS, the Payee and the Company are parties to that certain Convertible Note and Warrant Purchase Agreement dated , (the “Agreement”), pur |
|
| January 15, 2014 |
Exhibit 99.1 -1- -2- -3- -4- -5- -6- -7- -8- -9- -10- -11- -12- -13- -14- -15- -16- -17- -18- -19- -20- -21- -22- -23- -24- -25- -26- -27- -28- -29- -30- -31- -32- |
|
| January 15, 2014 |
Regulation FD Disclosure, Financial Statements and Exhibits - UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 15, 2014 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 20-8753132 (Commission File Numb |
|
| January 14, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 30, 2013 OR [ ] TRANSITION REPORT UNDER SECTION 13 OF 15(d) OF THE EXCHANGE ACT OF 1934 From the transition period from to . Commission File Number 000-52735 METASTAT, INC. (E |
|
| December 23, 2013 |
Financial Statements and Exhibits, Other Events - UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 23, 2013 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 20-8753132 (Commission File Num |
|
| December 23, 2013 |
MetaStat, Inc. Announces Issuance of U.S. Patent for its MenaCalc™ Platform Exhibit 99.1 MetaStat, Inc. Announces Issuance of U.S. Patent for its MenaCalc™ Platform MONTCLAIR, N.J., December 23, 2013 - MetaStat, Inc. (MTST), a life science company focused on understanding and treating systemic metastasis, announced today that the United States Patent and Trademark Office (USPTO) has issued US Patent Number US 8,603,738 entitled: "METASTASIS SPECIFIC SPLICE VARIANTS OF MEN |
|
| December 12, 2013 |
Exhibit 99.1 MetaStat Announces Exclusive Worldwide License Agreements for the Alternative Splicing Program in the Epithelial to Mesenchymal Transition (EMT) in Epithelial Cancers MONTCLAIR, N.J., December 12, 2013 - MetaStat, Inc. (OTCBB: MTST), a life sciences company focused on understanding and treating systemic metastasis, today announced that the company has entered into two separate exclusi |
|
| December 12, 2013 |
Exhibit 10.17 CONFIDENTIAL TREATMENT REQUESTED. INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND MARKED WITH “****” OR OTHERWISE CLEARLY INDICATED. AN UNREDACTED VERSION OF THIS DOCUMENT HAS ALSO BEEN PROVIDED TO THE SECURITIES AND EXCHANGE COMMISSION. MASSACHUSETTS INSTITUTE OF TECHNOLOGY EXCLUSIVE PATENT LICENSE AGREEMENT -1- TABLE OF CONTENTS RECITALS 3 1. Definiti |
|
| December 12, 2013 |
Exhibit 10.16 CONFIDENTIAL TREATMENT REQUESTED. INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND MARKED WITH “****” OR OTHERWISE CLEARLY INDICATED. AN UNREDACTED VERSION OF THIS DOCUMENT HAS ALSO BEEN PROVIDED TO THE SECURITIES AND EXCHANGE COMMISSION. MASSACHUSETTS INSTITUTE OF TECHNOLOGY EXCLUSIVE PATENT LICENSE AGREEMENT -1- TABLE OF CONTENTS RECITALS 3 1. Definiti |
|
| December 12, 2013 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits - UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 7, 2013 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 20-8753132 (Commission File Numb |
|
| November 21, 2013 |
COMMON STOCK PURCHASE WARRANT METASTAT, INC. Exhibit 4.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
| November 21, 2013 |
2014 CONVERTIBLE NOTE AND WARRANT PURCHASE AGREEMENT Exhibit 10.1 2014 CONVERTIBLE NOTE AND WARRANT PURCHASE AGREEMENT This 2014 Convertible Note and Warrant Purchase Agreement, dated as of November , 2013 (this “Agreement”), is entered into by and among MetaStat, Inc., a Nevada corporation (the “Company”), and the other signatories hereto (each a “Lender” and collectively, the “Lenders”). RECITALS A. On the terms and subject to the conditions set f |
|
| November 21, 2013 |
METASTAT, INC. 2014 Convertible Promissory Note Exhibit 4.1 THIS NOTE AND THE SECURITIES INTO WHICH IT IS CONVERTIBLE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES LAWS AND MAY NOT BE SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS REGISTERED UNDER THE SECURITIES ACT AND UNDER APPLICABLE STATE SECURITIES LAWS OR UNLESS METASTAT, INC. SHALL HAVE RECEIVED AN OPINION OF COUN |
|
| November 21, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 15, 2013 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 20-8753132 (Commission File Num |
|
| October 15, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended August 31, 2013 OR [ ] TRANSITION REPORT UNDER SECTION 13 OF 15(d) OF THE EXCHANGE ACT OF 1934 From the transition period from to . Commission File Number 000-52735 METASTAT, INC. (Exa |
|
| September 10, 2013 |
Exhibit 10.3 AGREEMENT OF LEASE LONG ISLAND HIGH TECHNOLOGY INCUBATOR, INC. METASTAT, INCORPORATED September 1, 2013 – August 31, 2014 -1- AGREEMENT OF LEASE This Lease dated this First day of September, Two Thousand and Thirteen is by and between LONG ISLAND HIGH TECHNOLOGY INCUBATOR, INC., a nonprofit educational corporation existing under the laws of the State of New York, having its principal |
|
| September 10, 2013 |
METASTAT, INC. EMPLOYMENT AGREEMENT Exhibit 10.2 METASTAT, INC. EMPLOYMENT AGREEMENT This Employment Agreement (this “Agreement”) is made and entered into on September 15, 2013 (the “Effective Date”) by and between MetaStat, Inc. (the “Company”) and Matthew O’Connor (“Employee”). The Company and Employee are hereinafter collectively referred to as the “Parties”, and individually referred to as a “Party”. Recitals A. The Company desi |
|
| September 10, 2013 |
Exhibit 99.1 MetaStat Announces Commencement of Its Comprehensive Drug Development Program with Significant New Hires and Research Facility Opening Montclair, N.J., September 10, 2013– MetaStat Inc. (OTCBB: MTST), a life science company focused on understanding and treating systemic metastasis, today announced that it has commenced its comprehensive drug development program with the hiring of Eliz |
|
| September 10, 2013 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): September 3, 2013 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 (Commission File Number) 20-875 |
|
| September 10, 2013 |
METASTAT, INC. EMPLOYMENT AGREEMENT Exhibit 10.1 METASTAT, INC. EMPLOYMENT AGREEMENT This Employment Agreement (this “Agreement”) is made and entered into on September 3, 2013 (the “Effective Date”) by and between MetaStat, Inc. (the “Company”) and Elizabeth Buck (“Executive”). The Company and Executive are hereinafter collectively referred to as the “Parties”, and individually referred to as a “Party”. Recitals A. The Company desir |
|
| July 15, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended May 31, 2013 OR [ ] TRANSITION REPORT UNDER SECTION 13 OF 15(d) OF THE EXCHANGE ACT OF 1934 From the transition period from to . Commission File Number 000-52735 METASTAT, INC. (Exact |
|
| May 28, 2013 |
METASTAT, INC. AMENDED AND RESTATED 2012 OMNIBUS SECURITIES AND INCENTIVE PLAN Exhibit 10.4 METASTAT, INC. AMENDED AND RESTATED 2012 OMNIBUS SECURITIES AND INCENTIVE PLAN Table of Contents METASTAT, INC. AMENDED AND RESTATED 2012 OMNIBUS SECURITIES AND INCENTIVE PLAN TABLE OF CONTENTS ARTICLE I PURPOSE 1 ARTICLE II DEFINITIONS 1 ARTICLE III EFFECTIVE DATE OF PLAN 6 ARTICLE IV ADMINISTRATION 6 Section 4.1 Composition of Committee 6 Section 4.2 Powers 6 Section 4.3 Additional |
|
| May 28, 2013 |
METASTAT, INC. EMPLOYMENT AGREEMENT Exhibit 10.13 METASTAT, INC. EMPLOYMENT AGREEMENT This Employment Agreement (this “Agreement”) is made and entered into on May 27, 2013 (the “Effective Date”) by and between MetaStat, Inc. (the “Company”) and Oscar L. Bronsther (“Executive”). The Company and Executive are hereinafter collectively referred to as the “Parties”, and individually referred to as a “Party”. Recitals A. The Company desir |
|
| May 28, 2013 |
METASTAT, INC. EMPLOYMENT AGREEMENT Exhibit 10.14 METASTAT, INC. EMPLOYMENT AGREEMENT This Employment Agreement (this “Agreement”) is made and entered into on May 27, 2013 (the “Effective Date”) by and between MetaStat, Inc. (the “Company”) and Warren C. Lau (“Executive”). The Company and Executive are hereinafter collectively referred to as the “Parties”, and individually referred to as a “Party”. Recitals A. The Company desires as |
|
| May 28, 2013 |
METASTAT, INC. EMPLOYMENT AGREEMENT Exhibit 10.15 METASTAT, INC. EMPLOYMENT AGREEMENT This Employment Agreement (this “Agreement”) is made and entered into on May 27, 2013 (the “Effective Date”) by and between MetaStat, Inc. (the “Company”) and Daniel H. Schneiderman (“Executive”). The Company and Executive are hereinafter collectively referred to as the “Parties”, and individually referred to as a “Party”. Recitals A. The Company d |
|
| May 28, 2013 |
U.S. SECURITIES AND EXCHANGE COMMISSION U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (MARK ONE) [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended February 28, 2013 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission file number: 000-52735 METASTAT, INC. (Exa |
|
| April 17, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 12, 2013 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 20-8753132 (Commission File Number |
|
| April 17, 2013 |
METASTAT, INC. ADVISORY AGREEMENT Exhibit 10.1 METASTAT, INC. ADVISORY AGREEMENT This Advisory Agreement (this “Agreement”) is made and entered into on April 12, 2013 (the “Effective Date”) by and between MetaStat, Inc. (the “Company”) and David Epstein, Ph.D. (“Advisor”). The Company and Advisor are hereinafter collectively referred to as the “Parties”, and individually referred to as a “Party”. Recitals A. The Company desires as |
|
| April 17, 2013 |
MetaStat Appoints David Epstein, Ph.D. as Advisor to Lead Drug Discovery Exhibit 99.1 MetaStat Appoints David Epstein, Ph.D. as Advisor to Lead Drug Discovery MONTCLAIR, N.J., April 15, 2013 /PRNewswire/ - MetaStat, Inc. (OTCBB: MTST), a life science company focused on understanding and treating systemic metastasis, announced today the appointment of David Epstein, Ph.D. as Advisor for MetaStat’s Drug Discovery & Development efforts. In addition, MetaStat intends to ap |
|
| April 15, 2013 |
Unregistered Sales of Equity Securities - UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 5, 2013 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 20-8753132 (Commission File Number) |
|
| April 9, 2013 |
MTST / MetaStat, Inc. / BALK MATTHEW Passive Investment SC 13G/A 1 formsc13ga-04092013040402.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* MetaStat, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 71942A208 (CUSIP Number) April 5 , 2013 (Date of Event Which Requires Filing of this Statement) Check the ap |
|
| March 1, 2013 |
CONVERTIBLE NOTE AND WARRANT PURCHASE AGREEMENT Exhibit 10.1 CONVERTIBLE NOTE AND WARRANT PURCHASE AGREEMENT This Convertible Note and Warrant Purchase Agreement, dated as of , 2013 (this “Agreement”), is entered into by and among MetaStat, Inc., a Nevada corporation (the “Company”), and the other signatories hereto (each a “Lender” and collectively, the “Lenders”). RECITALS A. On the terms and subject to the conditions set forth herein, Lender |
|
| March 1, 2013 |
COMMON STOCK PURCHASE WARRANT METASTAT, INC. Exhibit 4.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
| March 1, 2013 |
METASTAT, INC. Convertible Promissory Note Exhibit 4.1 THIS NOTE AND THE SECURITIES INTO WHICH IT IS CONVERTIBLE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES LAWS AND MAY NOT BE SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS REGISTERED UNDER THE SECURITIES ACT AND UNDER APPLICABLE STATE SECURITIES LAWS OR UNLESS METASTAT, INC. SHALL HAVE RECEIVED AN OPINION OF COUN |
|
| March 1, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 28, 2013 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 (Commission File Number) 20-875 |
|
| February 1, 2013 |
MTST / MetaStat, Inc. / ONE EAST PARTNERS MASTER L.P. - SCHEDULE 13G Passive Investment Schedule 13G Securities and Exchange Commission, Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No. )* MetaStat, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 59140A104 (CUSIP Number) December 31, 2012 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pur |
|
| January 14, 2013 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 30, 2012 OR [ ] TRANSITION REPORT UNDER SECTION 13 OF 15(d) OF THE EXCHANGE ACT OF 1934 From the transition period from to . Commission File Number 000-52735 METASTAT, INC. (Exact name of s |
|
| January 8, 2013 |
Financial Statements and Exhibits, Other Events - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 7, 2013 Commission File Number: 000-52735 MetaStat, Inc. |
|
| January 8, 2013 |
MetaStat, Inc. Announces Completion of 500 Patient Breast Cancer Trial MetaStat, Inc. Announces Completion of 500 Patient Breast Cancer Trial Over 500 breast cancer patients have been evaluated within the previously projected timeline and budget. MONTCLAIR, N.J., Jan. 7, 2013 /PRNewswire/ - MetaStat, Inc. (MTST), ("MetaStat" or the "Company"), a life science company focused on understanding and treating systemic metastasis, announced today that a 500 patient trial in |
|
| December 26, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 21, 2012 Commission File Number: 000-52735 MetaStat, Inc. |
|
| December 20, 2012 |
Regulation FD Disclosure, Financial Statements and Exhibits - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 19, 2012 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 (Commission File Number) 20-875 |
|
| December 20, 2012 |
Exhibit 99.1 -1- -2- -3- -4- -5- -6- -7- -8- -9- -10- -11- -12- -13- -14- -15- -16- -17- -18- -19- -20- -21- -22- |
|
| November 13, 2012 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 13, 2012 MetaStat, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-52735 (Commission File Number) 20-875 |
|
| November 13, 2012 |
CODE OF ETHICS OF METASTAT, INC. APPLICABLE TO DIRECTORS, OFFICERS AND EMPLOYEES Exhibit 14.1 CODE OF ETHICS OF METASTAT, INC. APPLICABLE TO DIRECTORS, OFFICERS AND EMPLOYEES To promote the ethical conduct and integrity generally of MetaStat, Inc. (the “Company”), and to promote accurate, fair and timely reporting of the Company's financial results and condition and other information the Company releases to the public market and include in reports it files with the Securities |
|
| October 18, 2012 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended August 31, 2012 OR ¨ TRANSITION REPORT UNDER SECTION 13 OF 15(d) OF THE EXCHANGE ACT OF 1934 From the transition period from to . Commission File Number 000-52735 METASTAT, INC. (Exact name of small b |
|
| October 15, 2012 |
- THIS IS A NT 10-Q ATTACHMENT FILE IN HTM FORMAT. OMB APPROVAL OMB Number: 3235-0058 Expires: July 31, 2012 Estimated average burden hours per response . |
